Getein Biotech, Inc (SHA:603387)

Getein Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	568.87	484.33	646.25	968.9	801.5	659.48
Short-Term Investments	-	-	-	-	-	10
Trading Asset Securities	602.37	451.91	511.14	612.68	594.92	467.36
Cash & Short-Term Investments	1,171	936.24	1,157	1,582	1,396	1,137
Cash Growth	23.98%	-19.11%	-26.82%	13.26%	22.83%	681.82%
Accounts Receivable	409.38	450.03	496.91	445.96	458.67	236.98
Other Receivables	27.31	136.46	42.55	37.45	20.81	10.86
Receivables	436.69	586.49	539.45	483.41	479.48	247.84
Inventory	224.58	229.71	269.39	252.3	211.99	160.68
Other Current Assets	203.05	398.75	433.12	48.13	28.95	21.49
Total Current Assets	2,036	2,151	2,399	2,365	2,117	1,567
Property, Plant & Equipment	738.2	703.86	556.49	452.2	369.63	296.75
Long-Term Investments	88.42	215.9	223.6	142.86	75.69	71.15
Goodwill	26.14	26.14	26.14	26.14	26.14	0.31
Other Intangible Assets	142.76	113.79	103.91	77.21	63.59	36.09
Long-Term Accounts Receivable	5.21	8.23	9.25	10.93	-	-
Long-Term Deferred Tax Assets	46.43	43.18	35.48	14.92	10.42	8.01
Long-Term Deferred Charges	52.39	80.12	51.05	43.68	34.48	12.82
Other Long-Term Assets	799.64	429.24	273.63	4.56	3.21	15.67
Total Assets	3,935	3,772	3,679	3,138	2,700	2,008
Accounts Payable	142.94	73.73	102.95	110.97	95.91	55.58
Accrued Expenses	63.12	103.03	120.22	85	81.26	57.51
Short-Term Debt	650.38	641.29	551.94	464.37	364.79	95
Current Portion of Long-Term Debt	-	12.89	25.8	0.2	-	-
Current Portion of Leases	9.69	9.79	5.63	2.1	-	-
Current Income Taxes Payable	26.58	9.58	9.04	10.48	17.6	9.85
Current Unearned Revenue	51.48	38.17	75.37	94.29	36.05	39.69
Other Current Liabilities	127.63	89.39	67.12	46.08	61	59.25
Total Current Liabilities	1,072	977.86	958.06	813.48	656.61	316.88
Long-Term Debt	50	-	3	27.78	20	-
Long-Term Leases	3.28	2.71	4.65	2	-	-
Long-Term Unearned Revenue	18.94	20.88	23.47	5.87	7.81	3.16
Long-Term Deferred Tax Liabilities	23.39	27.41	24.2	13.96	10.94	4.18
Other Long-Term Liabilities	1.52	1.52	0.91	0.8	0.6	1.76
Total Liabilities	1,169	1,030	1,014	863.9	695.95	325.98
Common Stock	507.15	507.15	507.15	363.81	260.34	260.38
Additional Paid-In Capital	236.18	314.01	318.24	511.58	612.36	609.96
Retained Earnings	1,844	1,732	1,655	1,280	973.8	773.22
Treasury Stock	-	-	-	-50	-8.75	-18.86
Comprehensive Income & Other	8.82	5.87	1.69	1.37	0.23	0.27
Total Common Equity	2,596	2,559	2,482	2,106	1,838	1,625
Minority Interest	169.53	181.92	182.13	167.63	166.05	56.68
Shareholders' Equity	2,766	2,741	2,665	2,274	2,004	1,682
Total Liabilities & Equity	3,935	3,772	3,679	3,138	2,700	2,008
Total Debt	713.35	666.68	591.02	496.44	384.79	95
Net Cash (Debt)	457.88	269.56	566.37	1,085	1,012	1,042
Net Cash Growth	160.87%	-52.41%	-47.81%	7.27%	-2.90%	616.49%
Net Cash Per Share	0.90	0.53	1.11	2.12	1.99	2.03
Filing Date Shares Outstanding	507.15	507.15	507.15	507.15	507.21	510.34
Total Common Shares Outstanding	507.15	507.15	507.15	507.15	510.27	510.34
Working Capital	963.75	1,173	1,441	1,552	1,460	1,250
Book Value Per Share	5.12	5.05	4.89	4.15	3.60	3.18
Tangible Book Value	2,427	2,419	2,352	2,003	1,748	1,589
Tangible Book Value Per Share	4.79	4.77	4.64	3.95	3.43	3.11
Buildings	-	247.34	243.57	240.18	229.04	190.91
Machinery	-	529.3	440.02	296.94	240.51	187.77
Construction In Progress	-	205.76	86.37	80.86	35.59	11.6

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.